EA201591577A1 - Состав, содержащий соединение бензотиазолона - Google Patents

Состав, содержащий соединение бензотиазолона

Info

Publication number
EA201591577A1
EA201591577A1 EA201591577A EA201591577A EA201591577A1 EA 201591577 A1 EA201591577 A1 EA 201591577A1 EA 201591577 A EA201591577 A EA 201591577A EA 201591577 A EA201591577 A EA 201591577A EA 201591577 A1 EA201591577 A1 EA 201591577A1
Authority
EA
Eurasian Patent Office
Prior art keywords
benzotiazolone
compound
composition containing
hydroxybenzo
butoxyphenyl
Prior art date
Application number
EA201591577A
Other languages
English (en)
Other versions
EA026914B1 (ru
Inventor
Милу Ашур
Робин Алек Фэрхерст
Арно Грандери
Синдзи Хатакеяма
Магдалена Козичак-Хольбро
Никола Туфилли
Томас Улльрих
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of EA201591577A1 publication Critical patent/EA201591577A1/ru
Publication of EA026914B1 publication Critical patent/EA026914B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к фармацевтической композиции в твердой пероральной лекарственной форме, содержащей ацетатную соль (R)-7-(2-(1-(4-бутоксифенил)-2-метилпропан-2-иламино)-1- гидроксиэтил)-5-гидроксибензо[d]тиазол-2(3H)-она.
EA201591577A 2013-02-28 2014-02-26 Состав, содержащий соединение бензотиазолона EA026914B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361770584P 2013-02-28 2013-02-28
PCT/IB2014/059270 WO2014132205A1 (en) 2013-02-28 2014-02-26 Formulation comprising benzothiazolone compound

Publications (2)

Publication Number Publication Date
EA201591577A1 true EA201591577A1 (ru) 2015-12-30
EA026914B1 EA026914B1 (ru) 2017-05-31

Family

ID=50238437

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591577A EA026914B1 (ru) 2013-02-28 2014-02-26 Состав, содержащий соединение бензотиазолона

Country Status (31)

Country Link
US (1) US9623012B2 (ru)
EP (1) EP2961391B1 (ru)
JP (2) JP6230626B2 (ru)
KR (1) KR20150120386A (ru)
CN (1) CN104968337A (ru)
AU (1) AU2014222362B2 (ru)
BR (1) BR112015020059A2 (ru)
CA (1) CA2897565A1 (ru)
CL (1) CL2015001940A1 (ru)
CY (1) CY1119202T1 (ru)
DK (1) DK2961391T3 (ru)
EA (1) EA026914B1 (ru)
ES (1) ES2637802T3 (ru)
HK (1) HK1212213A1 (ru)
HR (1) HRP20171177T1 (ru)
HU (1) HUE034353T2 (ru)
IL (1) IL240495A0 (ru)
LT (1) LT2961391T (ru)
MA (1) MA38354B1 (ru)
MX (1) MX2015011290A (ru)
NZ (1) NZ709747A (ru)
PE (1) PE20151608A1 (ru)
PH (1) PH12015501701A1 (ru)
PL (1) PL2961391T3 (ru)
PT (1) PT2961391T (ru)
SA (1) SA515360952B1 (ru)
SG (1) SG11201505544RA (ru)
SI (1) SI2961391T1 (ru)
TN (1) TN2015000310A1 (ru)
WO (1) WO2014132205A1 (ru)
ZA (1) ZA201504863B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
SG10201704377PA (en) * 2012-08-30 2017-06-29 Novartis Ag Salts of benzothiazolone compound as beta-2-adrenoceptor agonist
PE20151608A1 (es) * 2013-02-28 2015-11-19 Novartis Ag Formulacion que comprende un compuesto de benzotiazolona

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
PE20050130A1 (es) 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
WO2005110990A1 (de) 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen
GB0426164D0 (en) * 2004-11-29 2004-12-29 Novartis Ag Organic compounds
DE102009003975A1 (de) * 2009-01-07 2010-07-08 Merck Patent Gmbh Benzothiazolonderivate
JO3192B1 (ar) * 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
PE20151608A1 (es) * 2013-02-28 2015-11-19 Novartis Ag Formulacion que comprende un compuesto de benzotiazolona

Also Published As

Publication number Publication date
US9623012B2 (en) 2017-04-18
SA515360952B1 (ar) 2016-07-10
MA38354A1 (fr) 2016-02-29
MA38354B1 (fr) 2016-09-30
EA026914B1 (ru) 2017-05-31
US20160000761A1 (en) 2016-01-07
CN104968337A (zh) 2015-10-07
CL2015001940A1 (es) 2015-10-30
JP6230626B2 (ja) 2017-11-15
SI2961391T1 (sl) 2017-08-31
SG11201505544RA (en) 2015-09-29
IL240495A0 (en) 2015-09-24
EP2961391A1 (en) 2016-01-06
AU2014222362B2 (en) 2016-07-21
PE20151608A1 (es) 2015-11-19
PT2961391T (pt) 2017-08-29
CY1119202T1 (el) 2018-02-14
AU2014222362A1 (en) 2015-07-23
ES2637802T3 (es) 2017-10-17
EP2961391B1 (en) 2017-05-17
JP2016510020A (ja) 2016-04-04
HK1212213A1 (en) 2016-06-10
LT2961391T (lt) 2017-07-25
HUE034353T2 (en) 2018-02-28
KR20150120386A (ko) 2015-10-27
PH12015501701A1 (en) 2015-10-12
HRP20171177T1 (hr) 2017-10-06
MX2015011290A (es) 2015-12-03
NZ709747A (en) 2018-04-27
WO2014132205A1 (en) 2014-09-04
TN2015000310A1 (en) 2017-01-03
JP2018035186A (ja) 2018-03-08
BR112015020059A2 (pt) 2017-07-18
CA2897565A1 (en) 2014-09-04
ZA201504863B (en) 2016-06-29
DK2961391T3 (en) 2017-09-04
PL2961391T3 (pl) 2017-10-31

Similar Documents

Publication Publication Date Title
PH12015501996A1 (en) Heterocyclic compounds and uses thereof
IL244206A0 (en) A pharmaceutical preparation containing a pyrimidine compound as an active ingredient
PH12016500072B1 (en) Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof
CL2016001737A1 (es) Derivados heterocíclicos bicíclicos como inhibidores de bromodominio
UY35683A (es) Polimorfo de inhibidores de tirosina quinasa de bazo (syk)
EA201690473A1 (ru) Комбинированный состав двух противовирусных соединений
EA201400754A3 (ru) Новые фосфатные соединения, способ их получения и фармацевтические композиции, содержащие их
MX2016000675A (es) Derivados de amino-metil-biarilo como inhibidores del factor de complemento d y usos de los mismos.
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
EP2961733A4 (en) Disulfide compounds for delivery of pharmaceutical agents
EA201592268A1 (ru) Дигидропиридиноновые ингибиторы mgat2
PH12018500378B1 (en) Novel annelated phenoxyacetamides
EP3037092A4 (en) Composition containing monoacetyldiglyceride compound as active ingredient for inhibiting blood cancer or metastasis
PL2777689T3 (pl) Nowa kompozycja farmaceutyczna do leczenia zakażeń grzybiczych
BR112014030720A8 (pt) composto, composição farmacêutica e usos de inibidores de fbx03
MX2015013224A (es) Inhibidores macrociclicos y biciclicos del virus de la hepatitis c.
EP3200877A4 (en) Low dose oral pharmaceutical composition of isotretinoin
EA201591259A1 (ru) Твёрдые формы производного хиназолина и их применение в качестве ингибитора braf
PH12016500577A1 (en) Piperazine derivatives and the use thereof as medicament
EA201600123A1 (ru) Производные 1-(пиперазин-1-ил)-2-([1,2,4]триазол-1-ил)этанона
CY1119202T1 (el) Συνθεση που περιεχει την ενωση βενζοθειαζολονης
BR112016008704A8 (pt) derivados de indol-urea glucopiranosil-substituídos, composições farmacêuticas, e seus usos
EA201690908A1 (ru) Пиразолопиримидиновые соединения
EP3424500A4 (en) PHARMACEUTICAL COMPOSITION WITH PYRROLO-CONDENSUS, 6-LOW HETEROCYCLIC COMPOUND
GB201407847D0 (en) Composition for the oral delivery of compounds

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY KZ RU